Institute of Pathology, University of Bern, Bern, Switzerland,
Oncology. 2020;98(6):396-402. doi: 10.1159/000500884. Epub 2019 Jun 7.
Synoptic reporting in tumour pathology is defined by (1) completeness in terms of data elements as well as (2) a specific, laboratory value-like format. Adoption of synoptic reporting leads to more complete reporting of essential parameters, improved standardisation of diagnostic criteria and terminology, as well as easier retrieval of information. It is therefore associated with a high degree of satisfaction among end users including surgeons and oncologists and contributes to improvement of clinical care. Furthermore, synoptic reporting is an important step towards higher levels of data capture, which facilitate data exchange and analysis for quality assurance, cancer epidemiology and clinical and basic research. Increased interest in and adoption of synoptic reporting on a global level is stimulated by the International Collaboration on Cancer Reporting (ICCR) which publishes freely available, evidence-based datasets for reporting an increasing number of different cancer types. These developments pave the path for increased future application of synoptic reporting across the entire field of oncologic medicine, where it will likely deploy similar benefits to those in pathology. Given that synoptic reporting can be considered the most precise means available for reporting of medical findings, it may be predicted to be critical for the promise of precision medicine to become real.
(1) 在数据元素方面的完整性，以及 (2) 特定的、类似实验室值的格式。采用概要报告可更完整地报告基本参数，提高诊断标准和术语的标准化程度，更方便地检索信息。因此，它受到包括外科医生和肿瘤学家在内的最终用户的高度满意，有助于改善临床护理。此外，概要报告是实现更高数据捕获水平的重要步骤，这有助于为质量保证、癌症流行病学以及临床和基础研究进行数据交换和分析。国际癌症报告协作组织（ICCR）发布了免费的、基于证据的数据集，用于报告越来越多的不同癌症类型，这激发了全球范围内对概要报告的兴趣和采用。这些发展为在整个肿瘤医学领域更广泛地应用概要报告铺平了道路，它可能会带来与病理学类似的益处。鉴于概要报告可以被认为是报告医学发现的最精确手段，因此可以预测它对于精准医学的承诺成为现实至关重要。
